ID   SMB [Human]
AC   CVCL_S863
SY   SIM-1
DR   cancercelllines; CVCL_S863
DR   Cosmic; 1388896
DR   IARC_TP53; 23650
DR   Wikidata; Q54954936
RX   PubMed=2844401;
RX   PubMed=8378080;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8378080).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
RX   PubMed=2844401;
RA   Hamilton G., Fellinger E.J., Schratter I., Fritsch A.;
RT   "Characterization of a human endocrine tissue and tumor-associated
RT   Ewing's sarcoma antigen.";
RL   Cancer Res. 48:6127-6131(1988).
//
RX   PubMed=8378080;
RA   Kovar H., Auinger A., Jug G., Aryee D.N.T., Zoubek A.,
RA   Salzer-Kuntschik M., Gadner H.;
RT   "Narrow spectrum of infrequent p53 mutations and absence of MDM2
RT   amplification in Ewing tumours.";
RL   Oncogene 8:2683-2690(1993).
//